Alliance Defending Freedom attorneys representing a nonprofit pro-life pregnancy center and a nonprofit network of affiliated centers will be available for media interviews Thursday following a hearing at the U.S. Court of Appeals for the 9th Circuit in National Institute of Family and Life Advocates v. Bonta. ADF attorneys are seeking to protect the centers’ right to inform women about how supplemental progesterone can reverse the effects of abortion drugs.
NIFLA, along with SCV Pregnancy Center in Santa Clarita, is asking the court to halt California Attorney General Rob Bonta’s censorship of pro-life pregnancy centers that inform women about the option of progesterone therapy to reverse the effects of taking mifepristone—the first drug in the two-drug chemical abortion regimen—and potentially save their unborn babies’ lives. This treatment is commonly known as “abortion pill reversal.” Pregnancy centers wish to share that it may be possible for women to counteract mifepristone’s lethal effects if they change their minds and seek treatment within 72 hours of taking the first drug. But their scientifically backed speech about this option is chilled by the attorney general’s censorship campaign against similar speech.
Get the latest pro-life news and information on X (Twitter). Follow @LifeNewsHQ
“Access to information is a hallmark of a free society and is essential to making informed medical choices,” said ADF Senior Counsel Caleb Dalton, who will be arguing before the court. “Every woman should have the option to reconsider going through with a chemical abortion, and the pro-life pregnancy centers we represent truthfully inform women about that choice. We will urge the court to affirm the pregnancy centers’ freedom to tell the public about this lawful, life-saving treatment and end the attorney general’s censorship.”
In September 2023, Bonta sued Heartbeat International, a national network of pregnancy centers, and RealOptions Obria Medical Clinics, a chain of five pregnancy centers in California, for publishing information about abortion pill reversal, including that progesterone therapy is considered safe and can be an effective treatment. Bonta’s politically motivated lawsuit threatens other pregnancy centers in the state that have made, or would like to make, similar statements, so ADF attorneys filed a lawsuit on behalf of NIFLA and SCV. A federal district court denied the pregnancy centers’ original motion to stop the censorship while the case continues, prompting the appeal to the 9th Circuit.
Progesterone is a natural hormone needed to sustain pregnancy and has been used for decades to prevent miscarriage and preterm labor. Statistics show that abortion pill reversal has likely saved over 6,000 unborn lives and one study found a 64-68% success rate. Yet Bonta has targeted centers that tell women about this option because of the centers’ pro-life viewpoints and the content of their speech, which ADF attorneys argue is a violation of First Amendment rights.
